Lukas Werner has his background in medicinal and synthetic organic chemistry. He is the Head of the Service Technology Laboratory of the Institute of Biotechnology, Czech Academy of Sciences. The work of his team and coworkers concerns both medicinal chemistry and medicinal development. He has over 10 patents relating to medicinal chemistry and new medicaments worldwide. One of the drugs he has been participating in development is currently in the Phase 1 clinical trial for oncological indications. His team is specialized in design and preclinical development of mitochondriatargeted drugs with emphasis on hard-to-treat or orphan diseases.